Combination Therapy of Sorafenib and TACE for Unresectable HCC: A Systematic Review and Meta-Analysis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination Therapy of Sorafenib and TACE for Unresectable HCC: A Systematic Review and Meta-Analysis
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 3, Pages e91124
Publisher
Public Library of Science (PLoS)
Online
2014-03-21
DOI
10.1371/journal.pone.0091124
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sorafenib combined with transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma: a large-scale multicenter study of 222 patients
- (2013) Y. Zhao et al. ANNALS OF ONCOLOGY
- Sorafenib in combination with transarterial chemoembolization improves the survival of patients with unresectable hepatocellular carcinoma: A propensity score matching study
- (2013) Wei Bai et al. Journal of Digestive Diseases
- Treatment of Hepatocellular Carcinoma Combining Sorafenib and Transarterial Locoregional Therapy: State of the Science
- (2013) Joshua L. Weintraub et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Sorafenib Alone versus Sorafenib Combined with Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: Results of Propensity Score Analyses
- (2013) Gwang Hyeon Choi et al. RADIOLOGY
- The efficacy of TACE combined sorafenib in advanced stages hepatocellullar carcinoma
- (2012) Xu-Dong Qu et al. BMC CANCER
- Conventional transarterial chemoembolisation in combination with sorafenib for patients with hepatocellular carcinoma: a pilot study
- (2012) Wolfgang Sieghart et al. EUROPEAN RADIOLOGY
- Interim analysis of START: Study in asia of the combination of TACE (transcatheter arterial chemoembolization) with sorafenib in patients with hepatocellular carcinoma trial
- (2012) Young-Hwa Chung et al. INTERNATIONAL JOURNAL OF CANCER
- Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma
- (2012) Joong-Won Park et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC)
- (2012) Joong-Won Park et al. LIVER INTERNATIONAL
- Transarterial Chemoembolization Plus Sorafenib: A Sequential Therapeutic Scheme for HCV-Related Intermediate-Stage Hepatocellular Carcinoma: A Randomized Clinical Trial
- (2012) D. Sansonno et al. ONCOLOGIST
- The combination of sorafenib with transarterial chemoembolisation for hepatocellular carcinoma
- (2011) R. Cabrera et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma
- (2011) Masatoshi Kudo et al. EUROPEAN JOURNAL OF CANCER
- Phase II Trial of Sorafenib Combined With Concurrent Transarterial Chemoembolization With Drug-Eluting Beads for Hepatocellular Carcinoma
- (2011) Timothy M. Pawlik et al. JOURNAL OF CLINICAL ONCOLOGY
- Evolving strategies for the treatment of hepatocellular carcinoma: From clinical-guided to molecularly-taylored therapeutic options
- (2010) Luca Faloppi et al. CANCER TREATMENT REVIEWS
- Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization
- (2010) J.-L. Raoul et al. CANCER TREATMENT REVIEWS
- Continuous Administration of Sorafenib in Combination with Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma: Results of a Phase I Study
- (2010) J.-F. Dufour et al. ONCOLOGIST
- Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects
- (2010) Alejandro Forner et al. SEMINARS IN LIVER DISEASE
- Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib®versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation – HeiLivCa [ISRCTN24081794]
- (2008) K Hoffmann et al. BMC CANCER
- Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
- (2008) Scott M. Wilhelm et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now